EoCene Ltd.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EoCene Ltd. and other ETFs, options, and stocks.

About EOCN

Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. 

CEO
Allen J. Baharaff
CEOAllen J. Baharaff
Employees
6
Employees6
Headquarters
Ramat Gan, Tel Aviv
HeadquartersRamat Gan, Tel Aviv
Founded
2000
Founded2000
Employees
6
Employees6

EOCN Key Statistics

Market cap
4.61M
Market cap4.61M
Price-Earnings ratio
-0.34
Price-Earnings ratio-0.34
Dividend yield
Dividend yield
Average volume
39.75K
Average volume39.75K
High today
$4.16
High today$4.16
Low today
$4.06
Low today$4.06
Open price
$3.91
Open price$3.91
Volume
137.83K
Volume137.83K
52 Week high
$13.20
52 Week high$13.20
52 Week low
$3.29
52 Week low$3.29

Stock Snapshot

With a market cap of 4.61M, EoCene Ltd.(EOCN) trades at $4.08. The stock has a price-to-earnings ratio of -0.34.

During the trading session on 2026-09-10, EoCene Ltd.(EOCN) shares reached a daily high of $4.16 and a low of $4.06. At a current price of $4.08, the stock is +0.6% higher than the low and still -1.9% under the high.

Trading volume for EoCene Ltd.(EOCN) stock has reached 137.83K, versus its average volume of 39.75K.

Over the past 52 weeks, EoCene Ltd.(EOCN) stock has traded between a high of $13.20 and a low of $3.29.

Over the past 52 weeks, EoCene Ltd.(EOCN) stock has traded between a high of $13.20 and a low of $3.29.

EOCN News

TipRanks 1d
Galmed Rebrands as EoCene, Secures Nasdaq Compliance and Ends Yorkville Equity Line - TipRanks

...

Galmed Rebrands as EoCene, Secures Nasdaq Compliance and Ends Yorkville Equity Line - TipRanks
TipRanks 2d
Galmed Pharmaceuticals Regains Nasdaq Bid-Price Compliance, Avoids Delisting Risk

Galmed Pharmaceuticals ( (GLMD) ) has issued an update. On September 3, 2026, Galmed Pharmaceuticals was notified by Nasdaq that it had regained compliance wit...

People also own

Based on the portfolios of people who own EOCN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.